Inventor
BEKE LIJS
BE8 patents
Patents
8 patentsUS10653711B2May 19, 2020
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors
JANSSEN PHARMACEUTICA NV6 citations81
US11318157B2May 3, 2022
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors
JANSSEN PHARMACEUTICA NV1 citations70
US11883367B2Jan 30, 2024
6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors
JANSSEN PHARMACEUTICA NV0 citations60
US11993614B2May 28, 2024
Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors
JANSSEN PHARMACEUTICA NV0 citations59
US11098062B2Aug 24, 2021
Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors
JANSSEN PHARMACEUTICA NV0 citations59
US11999993B2Jun 4, 2024
Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitor
JANSSEN PHARMACEUTICA NV0 citations53
US11279970B2Mar 22, 2022
Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitor
JANSSEN PHARMACEUTICA NV0 citations53
US10898504B2Jan 26, 2021
Substituted nucleoside analogues for use as PRMT5 inhibitors
JANSSEN PHARMACEUTICA NV0 citations47